Top Penny Stocks To Watch In December 2024

In This Article:

Global markets have shown a mixed performance recently, with major U.S. stock indexes like the S&P 500 and Nasdaq hitting record highs, while smaller-cap stocks faced declines. In this context of diverging market trends, penny stocks—often representing smaller or newer companies—continue to attract attention for their potential to offer both affordability and growth opportunities. Despite being considered somewhat outdated, the term 'penny stocks' remains relevant as these investments can still present compelling opportunities when backed by strong financial health.

Top 10 Penny Stocks

Name

Share Price

Market Cap

Financial Health Rating

DXN Holdings Bhd (KLSE:DXN)

MYR0.515

MYR2.56B

★★★★★★

Tristel (AIM:TSTL)

£3.65

£174.08M

★★★★★★

Embark Early Education (ASX:EVO)

A$0.78

A$144.03M

★★★★☆☆

Hil Industries Berhad (KLSE:HIL)

MYR0.90

MYR298.75M

★★★★★★

ME Group International (LSE:MEGP)

£2.16

£813.81M

★★★★★★

Lever Style (SEHK:1346)

HK$0.87

HK$552.27M

★★★★★★

Bosideng International Holdings (SEHK:3998)

HK$4.05

HK$44.6B

★★★★★★

LaserBond (ASX:LBL)

A$0.575

A$65.64M

★★★★★★

Datasonic Group Berhad (KLSE:DSONIC)

MYR0.405

MYR1.13B

★★★★★★

Secure Trust Bank (LSE:STB)

£3.53

£67.32M

★★★★☆☆

Click here to see the full list of 5,699 stocks from our Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Ercros

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Ercros, S.A. is a Spanish company that manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals with a market cap of €327.34 million.

Operations: The company generates revenue from three main segments: Chlorine Derivatives (€375.76 million), Intermediate Chemicals (€193.57 million), and Pharmaceuticals (€63.57 million).

Market Cap: €327.34M

Ercros, S.A. operates in the chemicals sector with a market cap of €327.34 million, generating revenue from Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. Despite a satisfactory net debt to equity ratio of 36.3% and operating cash flow covering its debt well at 26.3%, Ercros faces challenges with declining earnings growth (-33.5%) and reduced revenue (€533.61 million) for the nine months ending September 2024 compared to the previous year (€600.94 million). The company reported a net loss of €7.8 million over this period, impacted by large one-off gains previously recorded.

BME:ECR Financial Position Analysis as at Dec 2024
BME:ECR Financial Position Analysis as at Dec 2024

Luzhou Bank

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Luzhou Bank Co., Ltd. operates in the People’s Republic of China, offering corporate and retail banking, financial market services, and other related services, with a market cap of HK$5.38 billion.